Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| §102 only | 1 (17%) |
| §112 only | 2 (33%) |
| No statute on record | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LANE, HOLLY JOANNA | 1 | 80.6% | +15.5% |
| BORGEEST, CHRISTINA M | 1 | 55.4% | +22.1% |
| LEVERETT, MARY CHANG | 1 | 60.5% | +22.6% |
| LUNDE, GRACE HENRY | 1 | 63.6% | +37.5% |
| DEBERRY, REGINA M | 1 | 49.8% | +30.7% |
| ALLEN, MARIANNE P | 1 | 59.8% | +18.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18029562 | CONNECTOR FOR SPINAL CORRECTION | LANE, HOLLY JOANNA | 14d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17926668 | Screening method for effective target - E3 ligase combinations | BORGEEST, CHRISTINA M | 26d overdue |
| 18029562 | CONNECTOR FOR SPINAL CORRECTION | LANE, HOLLY JOANNA | 14d |
| 17908545 | Membrane Ubiquitin ligases to target protein degradation | LUNDE, GRACE HENRY | 19d |
| 17242793 | COMPOSITIONS AND METHODS COMPRISING IgA ANTIBODY CONSTRUCTS | ALLEN, MARIANNE P | 27d |
| 17995525 | METHOD FOR IDENTIFYING SIGNATURES FOR PREDICTING TREATMENT RESPONSE | LEVERETT, MARY CHANG | 30d |
| 17242954 | IgA mediated killing of aberrant cells by CD47- SIRPalpha checkpoint inhibition of neutrophils | DEBERRY, REGINA M | 34d |
| Art Unit | Apps |
|---|---|
| 1647 | 2 |
| 3773 | 1 |
| 1675 | 1 |
| 1687 | 1 |
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18029562 | CONNECTOR FOR SPINAL CORRECTION | LANE, HOLLY JOANNA | 3773 | §102 | Final Rejection | 14d | Pending | Mar 30, 2023 |
| 17926668 | Screening method for effective target - E3 ligase combinations | BORGEEST, CHRISTINA M | 1675 | §103 | Non-Final OA | 26d overdue | Pending | Nov 21, 2022 |
| 17995525 | METHOD FOR IDENTIFYING SIGNATURES FOR PREDICTING TREATMENT RESPONSE | LEVERETT, MARY CHANG | 1687 | §103 | Non-Final OA | 30d | Pending | Oct 05, 2022 |
| 17908545 | Membrane Ubiquitin ligases to target protein degradation | LUNDE, GRACE HENRY | 1641 | Other | Final Rejection | 19d | Pending | Sep 01, 2022 |
| 17242954 | IgA mediated killing of aberrant cells by CD47- SIRPalpha checkpoint inhibition of neutrophils | DEBERRY, REGINA M | 1647 | §112 | Non-Final OA | 34d | Pending | Apr 28, 2021 |
| 17242793 | COMPOSITIONS AND METHODS COMPRISING IgA ANTIBODY CONSTRUCTS | ALLEN, MARIANNE P | 1647 | §112 | Non-Final OA | 27d | Pending | Apr 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial